BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Özgül Özdemir RB, Özdemir AT, Kırmaz C, Ovalı E, Ölmez E, Kerem H, Evrenos MK, Deniz G. Mesenchymal Stem Cells: a Potential Treatment Approach for Refractory Chronic Spontaneous Urticaria. Stem Cell Rev Rep 2021;17:911-22. [PMID: 33089453 DOI: 10.1007/s12015-020-10059-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Han Z, Gao X. Mesenchymal Stem/Stromal Cells in Allergic Disease Management. Allergic Disease - New Developments in Diagnosis and Therapy [Working Title] 2022. [DOI: 10.5772/intechopen.105763] [Reference Citation Analysis]
2 Lee D, Lee Y, Park S, Park H, Kang H, Kim J. Preventive Effects of a Human Hematopoietic Mesenchymal Stem Cell (hHMSC) Therapy in Ovalbumin-Induced Food Allergy. Biomedicines 2022;10:511. [DOI: 10.3390/biomedicines10020511] [Reference Citation Analysis]
3 Kumar V, Handa S. Stem Cells in Dermatology: What the Future May Hold. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-8845-4_2] [Reference Citation Analysis]
4 Kim EY, Kim HS, Hong KS, Chung HM, Park SP, Noh G. Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints. Stem Cell Res Ther 2021;12:539. [PMID: 34635172 DOI: 10.1186/s13287-021-02583-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]